CME Learning Center

Genitourinary Cancer

The Next Clinical Phase in Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer CME / ABIM MOC Are you up to date on the latest data on novel therapies being explored for patients with advanced prostate cancer?
Medscape Education Oncology, August 2023
New Hope for NRAS/BRAF-Mutated Advanced Solid Tumors: The Evaluation of Pan-RAF Inhibitors CME / ABIM MOC / CE Did you know that BRAF class II/III alterations comprise more than half of oncogenic BRAF alterations?
Medscape Education Oncology, August 2023
Adverse Event Management of TROP2-Targeting Antibody-Drug Conjugates (ADCs) CME / ABIM MOC / CE Do you know what the most common adverse events are with the various TROP2-targeting ADCs?
Medscape Education Oncology, July 2023
Advancing Care in Genitourinary Cancers: Key Developments in Prostate, Bladder, and Kidney Cancer CME / ABIM MOC Are you up to date on the latest data from this year’s scientific conferences in genitourinary (GU) cancers?
Medscape Education Oncology, June 2023
Medscape Onsite: Prostate and Bladder Cancer Updates CME / ABIM MOC Sharpen your clinical skills with updates on bladder and prostate cancer from leaders in the field.
Medscape Education Oncology, June 2023
Expert Perspectives on Health Equity and Disparities in Immunotherapy Cancer Care CME / ABIM MOC / CE Are you up to date on the disparities in immunotherapy cancer care and ways to achieve health equity?
Medscape Education Oncology, June 2023
Multiparametric MRI for Active Surveillance of Prostate Cancer CME / ABIM MOC How are you managing your prostate cancer patients on active surveillance?
Medscape Education Radiology, May 2023
Enhancing the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer With Immunotherapy-Based Regimens CME / ABIM MOC Did you know that immunotherapy-based regimens are being used to treat patients with high-risk non-muscle invasive bladder cancer (HR-NMIBC) leading to improved outcomes?
Medscape Education Urology, May 2023
Designing and Using Antibody-Drug Conjugates to Treat Solid Tumors CME / ABIM MOC How much do you know about antibody-drug conjugates (ADCs) for solid tumor management?
Medscape Education Oncology, April 2023
Advances in Urine-Based Prostate Cancer Screening Are you up to date on the recent advances in screening for prostate cancer?
Medscape Education Family Medicine, April 2023
Peer-to-Peer Clinical Connections: Sequencing Radioligand Therapies in Metastatic Castration-Resistant Prostate Cancer CME / ABIM MOC Did you know that radiopharmaceuticals for the treatment of metastatic castration-resistant prostate cancer (mCRPC) care have the potential to prolong survival and optimize the quality of life?
Medscape Education Oncology, March 2023
Medscape Onsite: Prostate and Bladder Cancer Updates From the Annual American Genitourinary Meeting CME / ABIM MOC Get the latest data on prostate and bladder cancer from the 2023 winter meetings.
Medscape Education Oncology, March 2023
What's Your Take? Perspectives on Immunotherapy for Early-Stage Solid Tumors CME / ABIM MOC Did you know? Immunotherapy is now being used for the neoadjuvant and adjuvant treatment of solid tumors -- find out more here!
Medscape Education Oncology, February 2023
Advances in Urine-Based Prostate Screening: Simplifying Screening in Primary Care With Novel Tests CME / ABIM MOC Did you know that screening for prostate cancer remains controversial? Listen to Dr Neal Shore discuss the latest on screening for prostate cancer.
Medscape Education Family Medicine, December 2022
Advances in Urine-Based Prostate Cancer Screening: Expanding Access to Quality Care CME / ABIM MOC Did you know that recent advances in diagnostics are expanding access to non-invasive approaches to screening for prostate cancer?
Medscape Education Family Medicine, December 2022
Overcoming Barriers to Bladder Cancer Care CME / ABIM MOC Are you aware of the most common presenting sign or symptom observed in patients with bladder cancer?
Medscape Education Oncology, December 2022
Case Review: Team-Based Approaches to Optimize Androgen Deprivation Therapy in Advanced Prostate Cancer CME / ABIM MOC / CE Do you know which class of agents used for androgen deprivation therapy (ADT) appears to have the most cardiovascular risk?
Medscape Education Oncology, November 2022
Treatment Approaches in Early-Stage Bladder Cancer CME / ABIM MOC Did you know that bladder cancer is highly treatable in the localized stages? Learn more about the latest in treating early-stage bladder cancer.
Medscape Education Oncology, November 2022
Antibody-Drug Conjugates 101: A Multidisciplinary Perspective of ADC Use in Solid Tumors CE Thinking about using antibody-drug conjugates (ADCs) in patients with solid tumors? Join this discussion with our experts for strategies and perspectives.
Medscape Education Oncology, October 2022
Metastatic Castration-Resistant Prostate Cancer: Updates From the 2022 European Annual Meeting CME / ABIM MOC Are you up-to-date on the latest data in metastatic castration-resistant prostate cancer (mCRPC) from the 2022 European Society of Medical Oncology Congress?
Medscape Education Oncology, October 2022

Are All Genes Created Equal in Prostate Cancer Outcomes? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, July 18, 2023
Does Metabolic Health Affect Cancer Risk? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, June 23, 2023
Medscape Now! Special Edition Hot Topics May 2023 CME / ABIM MOC / CE
Medscape Education Clinical Briefs, June 1, 2023
What Are the Risks to Spouses of Patients With Cancer? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, March 3, 2023
Do Nutrition and Physical Activity Affect Cancer Risk for Minority Women? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, November 4, 2022

CME Learning Center

Genitourinary Cancer

Latest Clinical Briefs

Further Reading